NCT07824973Not yet recruiting
Ketamine Treatment for Treatment-Resistant Depression - the Role of Framing
A Single-center Open-label Randomized Parallel-group Superiority Trial to Compare the Efficacy of Psychedelic and Biomedical Framing of Intravenous Ketamine for Treatment-resistant Depression - the KetSet Trial
Source: ClinicalTrials.gov · Last updated 17 Sept 2026
Brief summary (registry, in English)
Ketamine is a medicine used in psychiatry for treatment-resistant depression. This study compares two ways of framing ketamine treatment: a psychedelic framing and a biomedical framing. The study will examine whether the framing affects depressive symptoms, treatment experience, tolerability, and longer-term outcomes.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 11 Sept 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- Valdemar Landgren
- Diseases
- Depression
- NCT number
- NCT07824973
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 1 Sept 2026 to the primary completion date, 31 Dec 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- Patients who do not meet the inclusion criteria
Who the study is looking for
- Prescribed ketamine treatment for depression
- Able to understand study information and provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Brain Stimulation Clinic, Skaraborg's Hospital Coordinator of this site? Confirm its status | Skövde | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.